Mode
Text Size
Log in / Sign up
N/A N=22 Randomized Treatment

Comparing Silicone Hydrogel Contact Lens Wearers to Hydrogel Contact Lens Wearers and Non-lens Wearers

Myopia

Enrolled (actual)
22
Serious AEs
0.0%
Results posted
Jan 2024
Primary outcome: Primary: Limbal Redness - DDSH, DDH, Non-lens Groups — 0.41; 0.37; 0.44; 0.49 score on a scale

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
Control (Other); Test Lens (Device)
Age
Pediatric, Adult · 17+ yrs
Sex
All
Sponsor
CooperVision, Inc.
Primary completion
Oct 2022

Outcome Measures

OutcomeResultp-value
PRIMARY
Limbal Redness - DDSH, DDH, Non-lens Groups
0.41; 0.37; 0.44; 0.49; 0.40; 0.44
PRIMARY
Bulbar Redness DDSH, DDH, Non-lens Groups
0.76; 0.67; 0.79; 0.86; 0.83; 0.71
PRIMARY
Limbal Vessel Ingrowth - DDSH, DDH, Non-lens Groups
2; 2; 0
PRIMARY
Limbal Redness - DDSH, DDH Groups
0.48; 0.33; 0.70; 0.43; 0.61; 0.43
PRIMARY
Bulbar Redness - DDSH, DDH Groups
0.87; 0.60; 1.00; 0.63; 0.89; 0.57
SECONDARY
Central Corneal Swelling (%) - DDSH, DDH Groups
9.67; 9.34; 7.68; 6.82; 5.17; 4.26

Summary

This study was a multi-site, prospective, randomized, non-masked, unilateral, non-dispensing study.

Eligibility Criteria

Inclusion Criteria

  • Is between 17 and 60 years of age inclusive (age matching required between all 3 study groups), and has full legal capacity to volunteer;
  • Has had a self-reported oculo-visual examination in the last two years.
  • Has read and signed an information consent letter;
  • Is willing and able to follow instructions and maintain the appointment schedule;
  • No previous history of overnight contact lens wear or PMMA (polymethylmethacrylate) lens wear.
  • Auto-refraction vertexed spherical equivalent between +4.00 and -8.00 (prescription matching required between groups 1 & 2). This criterion is non-applicable to participants in group 3.
  • Is found to be in one of the study groups matched by age (±5 years), ethnicity (Asian vs. non-Asian) and CL Rx (±2.00 D) according using the following criteria.

GROUP 1: For the past (minimum) 6 months has ONLY worn spherical DDSH lenses AND prior to wearing this lens they only wore SH material lenses in the past (minimum) 3 total years.

GROUP 2: For the past (minimum) 6 months has ONLY worn spherical DDH lenses AND prior to wearing this lens they only wore H material lenses in the past (minimum) 3 total years.

  • For groups 1 & 2, currently and for at least the previous 6 months has had habitual daily disposable wear schedule of at least 8 hrs a day, 5 days a week in only one material category - either silicone hydrogel or hydrogel material. This criterion is not-applicable to participants in group 3.
  • Is willing to wear the study contact lens in the randomized eye for 3 hours of eye closure on the second study day. This criterion is not-applicable to participants in group 3.
  • Has clear and healthy corneas and anterior eye and no active ocular disease;
  • Can achieve monocular HCVA of logMAR 0.10 or better in each eye with subjective refraction or pinhole.
  • Can achieve acceptable fit and comfort in the randomized eye with the study lens. This criterion will be confirmed at the baseline visit (V1). This criterion is not-applicable to participants in group 3.
  • Has a wearable pair of spectacles.

Exclusion Criteria

  • Is participating in any concurrent clinical trial;
  • Is unable/unwilling to provide permission for the study site to seek CL history from their eye care practitioner
  • Has any known active ocular disease and/or infection;
  • Has a systemic condition that in the opinion of the investigator may affect a study measure or interfere with contact lens wear; this may include, but not be limited to, diabetes, hyperthyroidism, recurrent herpes simplex/zoster, Sjogren's syndromes, xerophthalmia, acne rosacea, Stevens-Johnson syndromes, and systemic connective tissue disorders e.g. rheumatoid arthritis.
  • Is using any systemic or topical medications that in the opinion of the investigator may affect a study measure;
  • Has known sensitivity to fluorescein dye, topical anesthetic, or products to be used in the study;
  • Appears to have any active ocular pathology, ocular anomaly or severe insufficiency of lacrimal secretion (severe dry eye) that would affect the wearing of contact lenses;
  • Appears to have any signs of corneal inflammation or previous infection or corneal opacity/scar;
  • Is pregnant, lactating or planning a pregnancy at the time of enrolment (by verbal confirmation at the screening visit), due to potential ocular physiological changes, such as changes in the corneal shape and cell types;
  • Is aphakic;
  • Has undergone refractive error surgery, or has a history of any ocular surgery or injury.
  • Is a toric or multifocal contact lens wearer.
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT04886479). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search